Eden Research plc (FRA:9T7)

Market Cap	33.34M +105.6%
Revenue (ttm)	4.22M -8.1%
Net Income	-2.74M
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.0260
Previous Close	0.0360
Day's Range	0.0260 - 0.0360
52-Week Range	0.0150 - 0.0650
Beta	n/a
RSI	61.45
Earnings Date	May 6, 2026

About Eden Research

Eden Research plc, together with its subsidiaries, engages in the development and sale of biopesticides in Europe and the United Kingdom. The company offers foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatments under the Mevalone and Cedroz brands for crop protection applications. It also provides consume products, such as head-lice treatment, deodorants, odour neutralizer, and fragrances, as well as food flavourings and active ingredients; and animal health products co...

• Industry: Agricultural Chemicals
• Founded: 1995
• Employees: 23
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 9T7

Financial Performance

In 2024, Eden Research's revenue was 4.30 million, an increase of 34.79% compared to the previous year's 3.19 million. Losses were -1.91 million, -70.64% less than in 2023.

Financial numbers in GBP